Company intelligence / Profile preview

GenomeScan

Leiden, South Holland, Netherlandsgenomescan.nl ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

GenomeScan delivers accredited next-generation sequencing-based genetic analysis services to healthcare providers, academic institutions, pharmaceutical companies, and biotech firms. The company specializes in rapid turnaround of high-quality genomic data for diagnostics and research applications. It does not have its own clinical pipeline or drug candidates.

Therapeutic areas: Rare Diseases
Modalities: Next Generation Sequencing (NGS)Whole exome sequencingPanel sequencingTranscriptomicsEpigenetics
Industry: Molecular Diagnostics

Partnerships

Erasmus Medical CenterLeiden University Medical Center

Beyond the preview

Go deeper on GenomeScan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenomeScan.

Explore the full profile